Victory Capital Management Inc Editas Medicine, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 10,371 shares of EDIT stock, worth $28,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,371

Previous 10,572 1.9%

Holding current value

$28,727

Previous $49,000 28.57%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$3.39 - $5.96 $681 - $1,197	-201 Reduced 1.9%	10,371 $35,000
Q2 2024 Aug 05, 2024	SELL	$4.67 - $7.28 $317,088 - $494,304	-67,899 Reduced 86.53%	10,572 $49,000
Q1 2024 May 03, 2024	BUY	$7.03 - $11.07 $474,848 - $747,734	67,546 Added 618.27%	78,471 $582,000
Q4 2023 Feb 05, 2024	BUY	$6.25 - $11.11 $68,281 - $121,376	10,925 New	10,925 $110,000
Q1 2022 May 04, 2022	SELL	$14.08 - $27.63 $15.7 Million - $30.8 Million	-1,115,611 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$26.55 - $40.57 $87,561 - $133,799	-3,298 Reduced 0.29%	1,115,611 $29.6 Million
Q3 2021 Nov 02, 2021	BUY	$39.27 - $72.94 $42.3 Million - $78.5 Million	1,076,258 Added 2523.41%	1,118,909 $46 Million
Q2 2021 Aug 03, 2021	SELL	$31.29 - $56.64 $65,114 - $117,867	-2,081 Reduced 4.65%	42,651 $2.42 Million
Q1 2021 May 04, 2021	SELL	$39.71 - $90.58 $483,667 - $1.1 Million	-12,180 Reduced 21.4%	44,732 $1.88 Million
Q4 2020 Feb 01, 2021	SELL	$27.07 - $84.35 $245,145 - $763,873	-9,056 Reduced 13.73%	56,912 $3.99 Million
Q3 2020 Nov 09, 2020	BUY	$28.06 - $37.16 $234,329 - $310,323	8,351 Added 14.49%	65,968 $1.85 Million
Q2 2020 Aug 07, 2020	SELL	$18.5 - $34.34 $2.24 Million - $4.16 Million	-121,015 Reduced 67.75%	57,617 $1.7 Million
Q1 2020 May 04, 2020	SELL	$14.88 - $32.78 $102,344 - $225,460	-6,878 Reduced 3.71%	178,632 $3.54 Million
Q4 2019 Feb 06, 2020	BUY	$19.49 - $32.63 $42,800 - $71,655	2,196 Added 1.2%	185,510 $5.49 Million
Q4 2019 Feb 04, 2020	SELL	$19.49 - $32.63 $351,326 - $588,188	-18,026 Reduced 8.95%	183,314 $4.85 Million
Q3 2019 Nov 12, 2019	BUY	$22.49 - $26.81 $4.53 Million - $5.4 Million	201,340 New	201,340 $4.58 Million
Q1 2019 May 03, 2019	SELL	$19.43 - $26.41 $1.2 Million - $1.64 Million	-62,002 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$18.19 - $31.79 $305,592 - $534,072	16,800 Added 37.17%	62,002 $1.41 Million
Q3 2018 Nov 01, 2018	SELL	$27.65 - $38.39 $66,913 - $92,903	-2,420 Reduced 5.08%	45,202 $1.44 Million
Q2 2018 Aug 02, 2018	SELL	$31.4 - $41.01 $83,838 - $109,496	-2,670 Reduced 5.31%	47,622 $1.71 Million
Q1 2018 May 04, 2018	BUY	$29.84 - $44.08 $165,910 - $245,084	5,560 Added 12.43%	50,292 $1.67 Million
Q4 2017 Feb 01, 2018	BUY	$21.89 - $31.34 $107,698 - $154,192	4,920 Added 12.36%	44,732 $1.38 Million
Q3 2017 Oct 27, 2017	SELL	$15.81 - $24.01 $32,252 - $48,980	-2,040 Reduced 4.87%	39,812 $956,000
Q2 2017 Aug 07, 2017	BUY	N/A	41,852	41,852 $702,000

Others Institutions Holding EDIT

# of Institutions

245

Shares Held

56.4M

Call Options Held

399K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $190M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Editas Medicine, Inc. Transaction History